AskVantage

Biotech and enhanced humans

Scientists have grown a human stomach in a petri dish

The more organs scientists can create outside of the human body the greater the benefits to human healthcare, this latest breakthrough takes us another step closer to realising the potential of regenerative medicine.

Key takeaways

  • When scientists want to understand how a drug works, they often turn to mice or other small animals to see how it works in them, then try to relate the results in humans.
  • Too much acid can create acid reflux disease, while an infection with the bacteria H.
  • Certain drugs, like Prilosec, treat this inflammation by reducing the amount of acid your body produces.
Cite or link to this article

Griffin, M. (2017) 'Scientists have grown a human stomach in a petri dish', 311 Institute, 14 January. Available at: https://www.311institute.com/scientists-have-grown-a-human-stomach-in-a-petri-dish/ (Accessed: 1 October 2026).

When scientists want to understand how a drug works, they often turn to mice or other small animals to see how it works in them, then try to relate the results in humans. But a mouse is not a human, and its body functions quite differently. So for a few years now, researchers have been working on a better approach - tiny organs, called organoids - that grow and live inside a petri dish, but that function like an actual organ.

This week researchers at Cincinnati Children’s Hospital Medical Center announced that they've managed to use pluripotent stem cells, stem cells that can be directed to grow into any other type of cell, to re-create a piece of working piece of human stomach - complete with the ability to produce acid and digestive enzymes - in a petri dish. And they say that it will help them to better understand how the real thing works, and what exactly happens when things go wrong.

The human stomach has multiple sections, all with different functions, and the researchers recreated a section of the stomach called the fundus, which is responsible for producing the acid and digestive enzymes necessary to break down the food we eat. But this vital section of the stomach is also particularly vulnerable to disease. Too much acid can create acid reflux disease, while an infection with the bacteria H. Pylori can cause ulcers and inflammation. By studying how these diseases progress in the stomach tissue, the scientists hope to be better equipped to treat them.

“You can watch diseases unfold under a microscope,” says James Wells, the lead author of the study, "and now we can see how the stomach heals itself."

For example, when too much acid builds up in the stomach, it often inflames the inner stomach lining. Certain drugs, like Prilosec, treat this inflammation by reducing the amount of acid your body produces. Seeing this healing process in action and what contributes to it, Wells says, gives researchers the opportunity to find new, and potentially better, methods for healing it - whether that's with drugs or with tweaks to the gut's microbiome. Their work was published this week in Nature.

This discovery comes two years after the researchers created another area of the stomach, the antrum, which is responsible for producing hormones that perform vital tasks like stimulating appetite using a similar technique.

The ultimate goal for many of the scientists in this field though is to create what's known as a Human on a Chip, a small credit card sized device that will allow scientists mix and match different organoids together in order to mimic the natural workings of the human body. And while some of these chips already exist, such as Heart on a Chip and ten other organs, it's thought that these chips, once mature enough will then allow scientists to run drug simulations quickly, and "in vitro," without the need for animal testing.

One day these chips, and this research, could even help to herald in a new era of regenerative medicine, where army field medics, doctors and scientists could grow and 3D print transplantable, personalised replacement organs from patients own stem cells that can one day be transplanted into their bodies without the need to wait for organ donors. But that work is at least a few years down the line. For now, these organoids will earn their keep by helping scientists make our guts a little less mysterious.

FAQ

Why does this matter?

The more organs scientists can create outside of the human body the greater the benefits to human healthcare, this latest breakthrough takes us another step closer to realising the potential of regenerative medicine.

Matthew Griffin

About the author

Matthew Griffin Founder, 311 Institute

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."

Read full bio

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.

An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.

As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.

Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.

What future do you need to see?

Choose one to get started on biotech and enhanced humans and the future of your organisation.

Where should Matthew reply?

Takes 30 seconds. No obligation. Matthew replies quickly. Privacy

Tag Cloud

Starburst opens that technology on the interactive 311 Starburst.

Sources and further reading

  1. Organoid en.wikipedia.org
  2. Cincinnati Children’s Hospital Medical Center cincinnatichildrens.org
  3. pluripotent stem cells en.wikipedia.org
  4. Fundus en.wikipedia.org
  5. Helicobacter pylori en.wikipedia.org
  6. Nature21021 nature.com
  7. Pylorus en.wikipedia.org

Source: first published by the 311 Institute on 14 January 2017. Cite as: Griffin, M. (2017). Scientists have grown a human stomach in a petri dish. 311 Institute. https://www.311institute.com/scientists-have-grown-a-human-stomach-in-a-petri-dish/

You are welcome to quote this article with credit and a link to the original.

Book a Keynote